Osteopontin as a therapeutic target for cancer-Reference-Cited by-同舟云学术

Osteopontin as a therapeutic target for cancer

Published:2014-06-04 Issue:8 Volume:18 Page:883-895
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Bandopadhyay Monalisa,Bulbule Anuradha,Butti Ramesh,Chakraborty Goutam,Ghorpade Priyanka,Ghosh Pompom,Gorain Mahadeo,Kale Smita,Kumar Dhiraj,Kumar Santosh,Totakura Kumar VS,Roy Gaurab,Sharma Priyanka,Shetti Dattatrya,Soundararajan Gowrishankar,Thorat Dhanashri,Tomar Deepti,Nalukurthi Radha,Raja Remya,Mishra Rosalin,Yadav Amit S,Kundu Gopal C

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728222.2014.925447

Reference100 articles.

1. Hallmarks of Cancer: The Next Generation

2. Migratory neighbors and distant invaders: tumor-associated niche cells

3. Osteopontin: role in cell signaling and cancer progression

4. The Multifaceted Roles of Osteopontin in Cell Signaling, Tumor Progression and Angiogenesis

5. Osteopontin: Role in immune regulation and stress responses

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteopontin: A Key Multifaceted Regulator in Tumor Progression and Immunomodulation;Biomedicines;2024-07-09

2. Enhancing sciatic nerve regeneration with osteopontin-loaded acellular nerve allografts in rats: Effects on macrophage polarization;Tissue and Cell;2024-06

3. SPP1 promotes tumor progression in esophageal carcinoma by activating focal adhesion pathway;Journal of Gastrointestinal Oncology;2024-06

4. Tumor cell derived osteopontin and prostaglandin E2 synergistically promote the expansion of myeloid derived suppressor cells during the tumor immune escape phase;International Immunopharmacology;2024-03

5. Combining Biomarkers for the Diagnosis of Metastatic Melanoma;Journal of Clinical Medicine;2023-12-28